|
1
|
Casaretto L, Sousa P and Mari J:
Chemotherapy versus support cancer treatment in advanced gastric
cancer: A meta-analysis. Braz J Med Biol Res. 39:431–440. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Zhan Z, Wu J, Zhang C, Yang Y,
Tong S, Sun Z, Qin L, Yang X and Dong W: Association among
polymorphisms in EGFR gene exons, lifestyle and risk of gastric
cancer with gender differences in Chinese Han subjects. Plos One.
8:e592542013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie Y, Zhi X, Su H, Wang K, Yan Z, He N,
Zhang J, Chen D and Cui D: A novel electrochemical microfluidic
chip combined with multiple biomarkers for early diagnosis of
gastric cancer. Nanoscale Re Lett. 10:4772015. View Article : Google Scholar
|
|
5
|
Buiatti E, Palli D, Decarli A, Amadori D,
Avellini C, Bianchi S, Bonaguri C, Cipriani F, Cocco P, Giacosa A,
et al: A case-control study of gastric cancer and diet in Italy:
II. Association with nutrients. Int J Cancer. 48:369–374. 2010.
View Article : Google Scholar
|
|
6
|
Shi Y and Zhou Y: The role of surgery in
the treatment of gastric cancer. J Surg Oncol. 101:687–692. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dang CV: The interplay between MYC and HIF
in the Warburg effect. Ernst Schering Found Symp Proc. pp. 1–53.
2007;
|
|
8
|
Rabbitts PH, Watson JV, Lamond A, Forster
A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R and
Rabbitts TH: Metabolism of c-myc gene products: c-myc mRNA and
protein expression in the cell cycle. Embo J. 4:2009–2015.
1985.PubMed/NCBI
|
|
9
|
Pelengaris S and Khan M: The many faces of
c-MYC. Arch Biochem Biophys. 416:129–136. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okuyama H, Endo H, Akashika T, Kato K and
Inoue M: Downregulation of c-MYC protein levels contributes to
cancer cell survival under dual deficiency of oxygen and glucose.
Cancer Res. 70:10213–10223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mai S and Mushinski JF: c-MYC-induced
genomic instability. J Environ Pathol Toxicol Oncol. 22:179–199.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu D, Wu J, Tang X, Hu F, Yang Y, Du J, Ye
S and Zhang R: Molecular cloning and tissue distribution of a
Schistosoma japonicum gene encoding AMY-1. Mol Med Rep.
4:1267–1271. 2011.PubMed/NCBI
|
|
14
|
Taira T, Maëda J, Onishi T, Kitaura H,
Yoshida S, Kato H, Ikeda M, Tamai K, Iguchi-Ariga SM and Ariga H:
AMY-1, a novel C-MYC binding protein that stimulates transcription
activity of C-MYC. Genes Cells. 3:549–565. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung HC and Kim K: Identification of MYCBP
as a beta-catenin/LEF-1 target using DNA microarray analysis. Life
Sci. 77:1249–1262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiurillo MA: Role of the Wnt/β-catenin
pathway in gastric cancer: An in-depth literature review. World J
Exp Med. 5:84–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu
J, Teng Y, Xia B, Wang R and Zou X: Interaction between
Wnt/β-catenin pathway and microRNAs regulates
epithelial-mesenchymal transition in gastric cancer (Review). Int J
Oncol. 48:2236–2246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sawa M, Masuda M and Yamada T: Targeting
the Wnt signaling pathway in colorectal cancer. Expert Opin Ther
Targets. 20:419–429. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Yan X, Ji LY, Ji XT, Wang P, Guo
SW and Li SZ: miR-139 functions as an antioncomir to repress glioma
progression through targeting IGF-1 R, AMY-1, and PGC-1β. Technol
Cancer Res Treat. 16:497–511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Byun E, Park B, Lim JW and Kim H:
Activation of NF-κB and AP-1 mediates hyperproliferation by
inducing β-catenin and c-Myc in Helicobacter pylori-infected
gastric epithelial cells. Yonsei Med J. 57:647–651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Washington K: 7th Edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Furusawa M, Onishi T, Taira T,
Iguchi-Ariga SM and Ariga H: AMY-1 is a trigger for the erythrocyte
differentiation of K562 cells. Int J Oncol. 16:339–345.
2000.PubMed/NCBI
|
|
25
|
Sakamuro D and Prendergast GC: New
Myc-interacting proteins: A second Myc network emerges. Oncogene.
18:2942–2954. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dhru HD, McDonough Winslow WS, Armstrong
B, Tuncali S, Eschbacher J, Kislin K, Loftus JC, Tran NL and Berens
ME: Reciprocal activation of transcription factors underlies the
dichotomy between proliferation and invasion of glioma cells. Plos
One. 8:e721342013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang X, Hu C, Arnovitz S, Bugno J, Yu M,
Zuo Z, Chen P, Huang H, Ulrich B, Gurbuxani S, et al: miR-22 has a
potent anti-tumour role with therapeutic potential in acute myeloid
leukaemia. Nat Commun. 7:114522016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin C, Yao E, Wang K, Nozawa Y, Shimizu H,
Johnson JR, Chen JN, Krogan NJ and Chuang PT: Regulation of Sufu
activity by p66β and Mycbp provides new insight into vertebrate
Hedgehog signaling. Genes Dev. 28:2547–2563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liao X, Siu MK, Au CW, Wong ES, Chan HY,
Ip PP, Ngan HY and Cheung AN: Aberrant activation of hedgehog
signaling pathway in ovarian cancers: Effect on prognosis, cell
invasion and differentiation. Carcinogenesis. 30:131–140. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feldmann G, Dhara S, Fendrich V, Bedja D,
Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C,
Jimeno A, et al: Blockade of hedgehog signaling inhibits pancreatic
cancer invasion and metastases: A new paradigm for combination
therapy in solid cancers. Cancer Res. 67:2187–2196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimizu M, Cohen B, Goldvasser P, Berman
H, Virtanen C and Reedijk M: Plasminogen activator uPA is a direct
transcriptional target of the JAG1-Notch receptor signaling pathway
in breast cancer. Cancer Res. 71:277–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Raghu H, Gondi CS, Dinh DH, Gujrati M and
Rao JS: Specific knockdown of uPA/uPAR attenuates invasion in
glioblastoma cells and xenografts by inhibition of cleavage and
trafficking of Notch-1 receptor. Mol Cancer. 10:1302011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hashimoto A, Hashimoto S, Ando R, Noda K,
Ogawa E, Kotani H, Hirose M, Menju T, Morishige M, Manabe T, et al:
GEP100-Arf6-AMAP1-cortactin pathway frequently used in cancer
invasion is activated by VEGFR2 to promote angiogenesis. PLoS One.
6:e233592011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakamuro D and Prendergast GC: New
Myc-interacting proteins: A second Myc network emerges. Oncogene.
18:2942–2954. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hermeking H, Rago C, Schuhmacher M, Li Q,
Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F,
et al: Identification of CDK4 as a target of c-MYC. Proc Natl Acad
Sci USA. 97:pp. 2229–2234. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Delaunay S, Rapino F, Tharun L, Zhou Z,
Heukamp L, Termathe M, Shostak K, Klevernic I, Florin A, Desmecht
H, et al: Elp3 links tRNA modification to IRES-dependent
translation of LEF1 to sustain metastasis in breast cancer. J Exp
Med. 213:2503–2523. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schambony A and Wedlich D: Wnt-5A/Ror2
regulate expression of XPAPC through an alternative noncanonical
signaling pathway. Dev Cell. 12:779–792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Willert K and Jones KA: Wnt signaling: Is
the party in the nucleus? Genes Dev. 20:1394–1404. 2006. View Article : Google Scholar : PubMed/NCBI
|
